$GMKG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Entia Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Entia Biosciences, Inc.. Get notifications about new insider transactions in Entia Biosciences, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 250,000 | 0 | 10,188,900 | 9.9 M to 10.2 M (+2.52 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 300,000 | 0 | 9,938,900 | 9.6 M to 9.9 M (+3.11 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 200,000 | 0 | 9,638,900 | 9.4 M to 9.6 M (+2.12 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.00 | 600,000 | 0 | 9,438,900 | 8.8 M to 9.4 M (+6.79 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman, CSTO | Grant | A | 0.18 | 1,861,170 | 325,705 | 8,838,900 | 7 M to 8.8 M (+26.67 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | Shelton Elliot | Secretary | Grant | A | 0.00 | 250,000 | 0 | 976,250 | 726.3 K to 976.3 K (+34.42 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | Shelton Elliot | Secretary | Grant | A | 0.00 | 200,000 | 0 | 726,250 | 526.3 K to 726.3 K (+38.00 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 850,000 | 600 K to 850 K (+41.67 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 600,000 | 300 K to 600 K (+100.00 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | TIMMINS TIMOTHY A | EVP, COO and CFO | Grant | A | 0.00 | 250,000 | 0 | 800,000 | 550 K to 800 K (+45.45 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | TIMMINS TIMOTHY A | EVP, COO and CFO | Grant | A | 0.00 | 300,000 | 0 | 550,000 | 250 K to 550 K (+120.00 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | TIMMINS TIMOTHY A | EVP, COO and CFO | Grant | A | 0.00 | 250,000 | 0 | 250,000 | 0 to 250 K |
| Dec 06 2016 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | Chairman,Chief Sci/ ... | Option Exercise | P | 0.10 | 40,000 | 4,000 | 40,000 | |
| May 24 2016 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President & CEO | Option Exercise | P | 0.13 | 25,000 | 3,125 | 25,000 | |
| Dec 09 2015 | GMKG | Entia Biosciences, ... | TAM CHEUK HO | 10% Owner | Grant | A | 0.01 | 1,025,462 | 10,255 | 1,521,228 | 495.8 K to 1.5 M (+206.84 %) |
| Dec 09 2015 | GMKG | Entia Biosciences, ... | WONG WAH ON EDWARD | 10% Owner | Grant | A | 0.01 | 1,025,462 | 10,255 | 1,521,228 | 495.8 K to 1.5 M (+206.84 %) |
| Dec 09 2015 | GMKG | Entia Biosciences, ... | Delta Group Investments Ltd | 10% Owner | Grant | A | 0.01 | 2,050,923 | 20,509 | 3,042,455 | 991.5 K to 3 M (+206.84 %) |
| Dec 09 2015 | GMKG | Entia Biosciences, ... | ANKA CAPITAL LTD | 10% Owner | Grant | A | 0.01 | 2,050,923 | 20,509 | 3,042,455 | 991.5 K to 3 M (+206.84 %) |
| Apr 28 2015 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Grant | A | 0.20 | 200,000 | 40,000 | 281,667 | 81.7 K to 281.7 K (+244.90 %) |
| Apr 28 2015 | GMKG | Entia Biosciences, ... | Shelton Elliot | Secretary | Grant | A | 0.20 | 200,000 | 40,000 | 326,250 | 126.3 K to 326.3 K (+158.42 %) |
| Apr 28 2015 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | CEO, President, Act ... | Grant | A | 0.20 | 600,000 | 120,000 | 4,757,200 | 4.2 M to 4.8 M (+14.43 %) |
| Apr 28 2015 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | Chief Operating Off ... | Grant | A | 0.20 | 550,000 | 110,000 | 1,171,671 | 621.7 K to 1.2 M (+88.47 %) |
| Nov 12 2014 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | COO, VP, Sales and ... | Buy | P | 0.30 | 429,640 | 128,892 | 621,671 | 192 K to 621.7 K (+223.73 %) |
| Nov 12 2014 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.30 | 1 | 0 | 1 | |
| Nov 12 2014 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.30 | 15,000 | 4,500 | 15,000 | |
| Nov 12 2014 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Buy | P | 0.30 | 2,162,980 | 648,894 | 4,171,825 | 2 M to 4.2 M (+107.67 %) |
| Nov 05 2014 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.30 | 15,000 | 4,500 | 15,000 | |
| Dec 19 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.65 | 1 | 1 | 1 | |
| Dec 19 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.65 | 20,000 | 13,000 | 20,000 | |
| Dec 19 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Buy | P | 0.38 | 62,505 | 23,752 | 2,482,488 | 2.4 M to 2.5 M (+2.58 %) |
| Dec 19 2013 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | COO, VP, Sales and ... | Buy | P | 0.38 | 52,089 | 19,794 | 201,031 | 148.9 K to 201 K (+34.97 %) |
| Nov 05 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 1.00 | 99,669 | 99,669 | 9,669 | |
| Nov 05 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | A | 1.00 | 7,313 | 7,313 | 7,313 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | Shelton Elliot | SECRETARY | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | COO, VP, Sales and ... | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | COO, VP, Sales and ... | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | A | 0.45 | 200,000 | 90,000 | 200,000 | |
| Oct 17 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | A | 0.45 | 400,000 | 180,000 | 400,000 | |
| Jul 22 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Buy | P | 0.38 | 131,579 | 50,000 | 2,419,981 | 2.3 M to 2.4 M (+5.75 %) |
| Jun 13 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.45 | 10,000 | 4,500 | 10,000 | |
| Jun 13 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 5.00 | 1 | 5 | 25,000 | |
| Jun 13 2013 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | P | 0.50 | 11,338 | 5,669 | 19,338 | |
| Jun 12 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | P | 0.50 | 16,025 | 8,013 | 21,025 | |
| Jun 12 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | P | 0.50 | 1,000 | 500 | 5,000 | |
| Jun 12 2013 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | COO, VP, Sales and ... | Buy | P | 0.38 | 131,579 | 50,000 | 148,942 | 17.4 K to 148.9 K (+757.81 %) |
| Feb 22 2013 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | Vice President | Option Exercise | A | 0.38 | 25,000 | 9,500 | 25,000 | |
| Jan 22 2013 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO, Act ... | Option Exercise | A | 0.50 | 1,000 | 500 | 4,000 | |
| Jun 19 2012 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 5.00 | 1 | 5 | 1 | |
| Jun 19 2012 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 0.55 | 150,000 | 82,050 | 150,000 | |
| Jun 19 2012 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 0.50 | 5,000 | 2,500 | 5,000 | |
| Dec 21 2011 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 0.06 | 1,000,000 | 60,000 | 1,000,000 | |
| Dec 21 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | President, CEO | Option Exercise | A | 0.06 | 1,000,000 | 60,000 | 1,000,000 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | VICE PRESIDENT | Option Exercise | A | 0.04 | 1,083,420 | 39,003 | 1,083,420 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | VICE PRESIDENT | Option Exercise | A | 0.05 | 1,083,420 | 50,921 | 1,083,420 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | VICE PRESIDENT | Option Exercise | A | 0.06 | 3,500,000 | 192,500 | 3,500,000 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | ANDRES DEVIN D. | VICE PRESIDENT | Grant | A | 0.04 | 694,500 | 25,002 | 694,500 | 0 to 694.5 K |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | PRESIDENT, CEO | Option Exercise | A | 0.04 | 1,389,000 | 50,004 | 1,389,000 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | PRESIDENT, CEO | Option Exercise | A | 0.05 | 1,389,000 | 65,283 | 1,389,000 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | PRESIDENT, CEO | Option Exercise | A | 0.06 | 5,000,000 | 275,000 | 5,000,000 | |
| Nov 01 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | PRESIDENT, CEO | Grant | A | 0.04 | 9,175,734 | 330,326 | 23,342,400 | 14.2 M to 23.3 M (+64.77 %) |
| Apr 29 2011 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | PRESIDENT, CEO | Grant | A | 0.00 | 666,666 | 0 | 10,666,666 | 10 M to 10.7 M (+6.67 %) |
| Jan 25 2011 | GMKG | Entia Biosciences, ... | Shelton Elliot | SECRETARY | Option Exercise | A | 0.09 | 1,000,000 | 85,000 | 1,000,000 | |
| Jan 25 2011 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | A | 0.09 | 1,000,000 | 85,000 | 1,000,000 | |
| Jan 04 2010 | GMKG | Entia Biosciences, ... | HAUSMAN MARVIN S MD | CEO | Option Exercise | J | 0.10 | 125,000 | 12,500 | 125,000 | |
| Dec 31 2009 | GMKG | Entia Biosciences, ... | SOBOL PHILIP A | Director | Option Exercise | J | 0.10 | 125,000 | 12,500 | 125,000 | |
| Oct 17 2008 | GMKG | Entia Biosciences, ... | Jesky TJ | Sell | P | 70,000.00 | 3,500,000 | 245,000,000,000 | 1,500,000 | 5 M to 1.5 M (-70.00 %) | |
| Oct 17 2008 | GMKG | Entia Biosciences, ... | DeStefano Mark | Sell | P | 60,000.00 | 3,000,000 | 180,000,000,000 | 1,500,000 | 4.5 M to 1.5 M (-66.67 %) |
Page: 1